Hematology

FDA Approves Abatacept to Proactively Treat Acute Graft-Versus-Host-Disease

December 16, 2021

Abatacept is now available for use in combination with certain immunosuppressants to prevent moderate to severe acute-graft-versus-host disease for select patients who have received unrelated donor hematopoietic stem cell transplant.